We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Hypoglycemia in Hospitalized Patients Linked to Increased Mortality Risk

By LabMedica International staff writers
Posted on 30 Nov 2016
Spontaneous and insulin-related hypoglycemia is common among hospitalized patients with and without diabetes mellitus (DM). The definition of hypoglycemia in hospitalized patients is poorly defined and thus the true prevalence of hypoglycemia during hospitalization is variable.

One complication of diabetes, hypoglycemia, occurs most often in people taking medications to manage their blood sugar. These treatments can raise insulin levels too high, which can in turn cause blood glucose levels to drop too low. Hypoglycemia can be dangerous and, depending on the severity, can lead to various symptoms, including dizziness, confusion, anxiety, seizure or loss of consciousness.

Image: A typical glucometer showing a blood glucose indicating severe hypoglycemia (Photo courtesy of the UCSF).
Image: A typical glucometer showing a blood glucose indicating severe hypoglycemia (Photo courtesy of the UCSF).

A team of medical scientists at the Rabin Medical Center (Petah Tikva, Israel) conducted a study in a large 1,300-bed university-affiliated tertiary medical center collected historical prospectively observational data which were extracted from the medical records of all patients admitted for any cause to the hospital’s medical wards between January 1, 2011 and December 31, 2013. This study included nearly 3,000 patients with hypoglycemia, defined as blood glucose levels lower than 70 mg/dL.

The team found that for patients with hypoglycemia, 31.9% had died at the end of the follow-up period. Mortality risk was higher in insulin-treated patients with moderate hypoglycemia (40-70 mg/dL), compared to patients without insulin treatment with similar glucose values. However, with severe hypoglycemia of less than 40 mg/dL, the increase in mortality risk was similar with insulin-related and non-insulin related hypoglycemia. The c cause of admission did not affect the association between glucose levels and mortality. Almost half the patients with hypoglycemia during hospitalization did not have pre- existing DM (1,452/2,947 patients, 49%). However, most of the patients with severe hypoglycemia had pre-existing DM (236/342 patients, 69%).

Amit Akirov, MD, the study senior author, said, “Hypoglycemia is common among hospitalized patients with and without diabetes mellitus. Our findings suggest that hypoglycemia, whether insulin-related or non-insulin related, is associated with short- and long-term mortality risk. These data are a timely reminder that hypoglycemia of any cause carries the association with increased mortality.” The study was published on November 17, 2016, in the Journal of Clinical Endocrinology & Metabolism.

Related Links:
Rabin Medical Center


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Clinical Informatics Platform
CLARION™
Pipette Calibration System
Artel PCS®

Latest Clinical Chem. News

Common HbA1c Assay May Miss Diabetes in People with Sickle Cell Trait
30 Nov 2016  |   Clinical Chem.

Blood Protein Panel Predicts Timing of ALS Symptom Onset
30 Nov 2016  |   Clinical Chem.

Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers
30 Nov 2016  |   Clinical Chem.



PURITAN MEDICAL